Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Suspended 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 218pembrolizumab 200Magnetic Resonance Spectroscopy 196Carboplatin 173Cisplatin 137Biopsy 133Nivolumab 131Paclitaxel 116Cyclophosphamide 113Radiotherapy 110Gemcitabine 103Dexamethasone 91durvalumab 90atezolizumab 76Radiation 71Lenalidomide 71Rituximab 68Pemetrexed 67Doxorubicin 67Bevacizumab 65Docetaxel 62Ipilimumab 59Etoposide 56olaparib 55Fluorouracil 52venetoclax 51Radiosurgery 50Oxaliplatin 50Taxes 49Prednisone 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Cell Count × 90 days × Clear all
NCT06318871 2026-05-11

Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Active not recruiting
5 enrolled
Genitourinary

Carcinoma, Renal Cell, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡